The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B-cell non-hodgkin lymphoma and mature B-cell leukemia: A retrospective analysis of enrolled cases in Japan

Pediatric Blood and Cancer

Volumn 51, Issue 2, 2008, Pages 188-192

  Fujita, Naoto ^a   Mori, Tetsuya ^b   Mitsui, Tetsuo ^c   Inada, Hiroko ^d   Horibe, Keizo ^e   Tsurusawa, Masahito ^f  

^a ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c YAMAGATA UNIVERSITY HOSPITAL   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^f AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Childhood; Mature B cell leukemia (B ALL); Non hodgkin lymphoma; Refractory; Relapsed; Stem cell transplantation

Indexed keywords

ASPARAGINASE; BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; HYDROCORTISONE; IDARUBICIN; IFOSFAMIDE; LYMPHOCYTE ANTIBODY; MELPHALAN; METHOTREXATE; MITOXANTRONE; PIRARUBICIN; PREDNISOLONE; PREDNISONE; RANIMUSTINE; RITUXIMAB; THIOTEPA; THYMOCYTE ANTIBODY; VINCRISTINE;

ADOLESCENT; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SENSITIVITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; WHOLE BODY RADIATION; INFANT; PRESCHOOL CHILD; PROGNOSIS; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKEMIA, B-CELL; LYMPHOMA, B-CELL; MALE; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 45549103506     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21585     Document Type: Article

References (21)

1. Cario MS, Sposto R, Perkins SL, et al. Burkitt's and Burkitt-like lymphoma in children and adolescent: A review of the Children's Cancer Group Experience. Br J Haematol 2003;120:660-670.
2. Patte C, Auperin A, Michon J, et al. The Société Française d'Oncologie Pédiatrique LMB89 protocol: Highly effective multi-agent chemotherapy tailored to the tumor burden and response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001;97:3370-3379.
3. Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood 1999;94:3294-3306.
4. Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's lymphoma in childhood. N Engl J Med 1996;334:1238-1248.
5. Patte C, Auperin A, Gerrard M, et al. Results of the randomised international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescent: It is possible to reduce treatment for the early responding patients. Blood 2007;109:2773-2780.
6. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999;17:1244-1253.
7. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximabe compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235-242.
8. Moskowitz CH, Bertino JR, Glassman JR, et al. Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and periferal-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. J Clin Oncol 1999;17:3776-3785.
9. Buhrer C, Hartmann R, Fengler R, et al. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblasitc leulemia predict response to salvage chemotherapy and outcome. J Clin Oncol 1996;14:2812-2817.
10. Velasquez WS, Mclaughlin P, Tucker S, et al. ESHAP-An effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow-up study. J Clin Oncol 1994;12:1169-1176.
11. Nakagawa A, Nakamura S, Nakamine H, et al. Pathology review for paediatric non-Hodgkin's lymphoma patients in Japan: A report from the Japan association of childhood leukaemia study (JACLS). Eur J Cancer 2004;40:725-733.
12. Attarbaschi A, Dworzak M, Steiner M, et al. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: A population-based analysis of the Austrian cooperative study group. Pediatr Blood Cancer 2005;44:70-76.
13. Atra A, Gerrard M, Hobson R, et al. Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols. Br J Haematol 2001;112:965-968.
14. Kobrinsky NL, Sposto R, Shah NR, et al. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and L-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group study CCG-5912. J Clin Oncol 2001;19:2390-2396.
15. Ladenstein R, Pearce R, Hartmann O, et al. High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: A report from the European lymphoma bone marrow transplantation registry. Blood 1997;90:2921-2930.
16. Philip T, Hartmann O, Pinkerton R, et al. Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: A report from the Sosiete Francaise d'Oncologie Pediatrique. Blood 1993;81:2003-2006.
17. Avet Loiseau H, Hartmann O, Valteau D, et al. High-dose chemotherapy containing busulfan followed by bone marrow transplantation in 24 children with refractory or relapsed non-Hodgkin's lymphoma. Bone Marrow Transplant 1991;8:465-472.
18. Kasamon YL, Jones RJ, Piantadosi S, et al. High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement. Biol Blood Marrow Transplant 2005;11:93-100.
19. Khouri IF, Saliba RM, Hosing C, et al. Concurrent administration of high-dose rituximab before and after autologus stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphoma. J Clin Oncol 2005;23:2240-2247.
20. Sandlund JT, Bowman L, Heslop H, et al. Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL. Cytotherapy 2002;4:253-258.
21. Bureo E, Ortega JJ, Munoz A, et al. Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 1995;15:353-359.